Hinai Al,Wali A.,Rasool T. A.,Rizvi S. G. .2017 .Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population. Oman J Ophthalmol, 10 : 177-183.
R. .2019 .Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. , 321 : 1880-1894.
Bressler S. B.,Odia I.,Glassman A. R.,Grover R. P.,S. R. P.,G. R. R. P.,Maguire L. M.,Melia M. G.,M. M. G. .2018 .. , : .
Report Year . .Changes in diabetic retinopathy severity when treating diabetic macular edema with ranibizumab: DRCR.net Protocol I 5. , 38 : 1896-1904.
Retinopathy Clinical Research Diabetic,N. Diabetic .2008 .A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid 5. , : .
. .photocoagulation for diabetic macular edema. Ophthalmology, 115 : 1447-145010.
R. ,Bressler L. P.,Ferris N. M.,Glassman F.,Hartnett A. R.,Ip E.,Kim M. S.,Kollman J. E.,C. J. E. .1960 .Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Archives of ophthalmology (Chicago, 127 : 245-251.
Distefano L. N.,Garcia-Arumi J.,Martinez-Castillo V.,Boixadera A. .2017 .Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review. Journal of ophthalmology, : 2407037-2407037.
Ghoraba H. H.,Elgouhary M.,Elgemai S. M.,Abdelfattah E. E. M.,Ghoraba H. M.,Heikal H. H.,M. A. H. H. .2018 .Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middleincome countries. Clin Ophthalmol, 12 : 2383-2391.
Habot-Wilner Z.,Noronha G.,Wykoff C. C. .2019 .. , : .
. .Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach. Acta ophthalmologica, 97 : 460-472.
Tayyab; Chaudhry Nasir Ahmed; M. Ali Ayaz Sadiq Haroon .2020 .. , : .
. .Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pakistan journal of medical sciences, Jan-Feb; 36(2), : 42-47.
Romero-Aroca P.,Reyes-Torres J.,Baget-Bernaldiz M.,BlascoSuñe C. .2014 .Laser treatment for diabetic macular edema in the 21st. century. Current diabetes reviews, 10 : 100-112.
Villegas V. M.,Schwartz S. G. .2018 .Current and Future Pharmacologic Therapies for Diabetic Retinopathy. Curr Pharm Des, 24 : 4903-4910.
Wykoff CC,Khurana RN,Lampen SIR,Noronha G,Brown DM,HULK StudyGroup DM .2018 .Suprachoroidal Triamcinolone Acetonide for Diabetic Macular Edema:The HULK Trial. , : .
Bakbak B,Ozturk BT,Gonul S,Gedik S. .2016 .The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs. Oman journal of ophthalmology, 9(1) : 44.
Ishibashi T,Li X,Koh A,Lai TY,Lee F-L,Lee W-K F-L .2015 .The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema. Ophthalmology, 122(7) : 1402-15.
Sarhan A-RE,Mandour SS,Zayed AZ .2019 .Evaluation of intravitreal injection of ranibizumab in diabetic macular edema. Menoufia Medical Journal, 32(4) : 1447.
Hall L,Frizzera LP,Coelho LF,Carricondo PC,Oyamada MK,Pimentel SLG .2019 .Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion. International journal of retina and vitreous, 5(1) : 32.
Kaya M,Karahan E,Ozturk T,Kocak N,Kaynak S. .2018 .Effectiveness of intravitreal ranibizumab for diabetic macular edema with serous retinal detachment. Korean Journal of Ophthalmology, 32(4) : 296-302.
Schechet SA,Adams OE,Eichenbaum DA,Hariprasad SM .2019 .Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema. BMJ open ophthalmology, 4(1) : e000271.